Jennifer Swan > Dechert LLP > Philadelphia, United States > Lawyer Profile

Dechert LLP
United States
Jennifer Swan photo

Work Department

Intellectual Property




Jennifer S. Swan focuses her practice on developing, enforcing and defending patent rights. Ms. Swan has extensive experience representing companies in Hatch-Waxman litigation and in the chemical, biotechnology and medical device areas. Ms. Swan also has experience assisting life science startups in strategic counseling.

Ms. Swan has been involved in all aspects of pre-trial, trial and post-trial proceedings in federal district courts, including the District of New Jersey, District of Delaware, Northern District of California, Eastern District of Pennsylvania and Northern District of Illinois. She has unique experience regarding litigation practice in the Northern District of California, having clerked for two judges in the district.

Ms. Swan also has participated in numerous appellate proceedings at the U.S. Court of Appeals for the Federal Circuit and proceedings at the U.S. Supreme Court. She has been involved in some of the most significant recent developments in patent law, including joint infringement and the written description requirement under section 112. She has also been involved in interference proceedings in federal district courts and proceedings before the Federal Trade Commission.


  • American Intellectual Property Law Association
  • Federal Circuit Bar Association


  • University of Pittsburgh, B.A., Biological Anthropology
  • University of Pittsburgh, J.D.

Lawyer Rankings

United States > Intellectual property > Patents: litigation (full coverage)

Dechert LLP‘s practice garners praise for being ‘technically sophisticated, smart, transparent, and ethical’. The group headed by Philadelphia’s Martin J Black , which is able to ‘identify strengths and weaknesses as cases mature’, regularly acting on the plaintiff’s side, has a particular strength in the life sciences sector with a dedicated Hatch-Waxman litigation team. The New York-based Katherine Helm has a focus on pharmaceutical and biotech patent litigation. In 2021 Howard Levine and Jennifer Swan joined from Finnegan, Henderson, Farabow, Garrett & Dunner LLP. Silicon Valley’s Nisha Patel left the firm for an in-house position.